EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effectiveness and safety of high-definition transcranial direct current stimulation in patients with mild cognitive impairment: A randomized, triple-blind, sham-controlled trial

Che-Sheng Chu iD, Hsin-An Chang, Yu-Te Lin, Hsiu-Chu Shen, Chih-Kuang Liang iD, Ying-Hsin Hsu iD, Chih-Chuan Pan, Hsin-Ya Kuo, Wei-Zhe Liang, Shiou-Lan Chen, Cheng-Sheng Chen

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251376547 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Che-Sheng Chu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Transcranial Direct Current Stimulation. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Science and Technology, Kaohsiung Veterans General Hospital, National Health Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-definition transcranial direct current stimulation (HD-tDCS), a non-invasive brain stimulation technique, has shown potential for improving cognition in patients with mild cognitive impairment (MCI).

Objective

To evaluate whether HD-tDCS enhances cognitive function in individuals with MCI.

Methods

This was a triple-blind, randomized, sham-controlled study. The anodal electrode was placed over the left dorsolateral prefrontal cortex (DLPFC) and surrounded by four cathode electrodes (2 mA for 25 min, daily for 10 sessions). Tests were performed at baseline, after 2-week stimulation, at 1 month, and at 3 months. The primary outcome was global cognition measured by Cognitive Abilities Screening Instrument and secondary outcomes included memory, language, executive function, and attention tests. Group differences were analyzed using linear mixed model (LMM).

Results

Fifty patients with MCI were randomized to the sham (n = 25) and HD-tDCS groups (n = 25). No significant differences were observed between the HD-tDCS and sham groups in global cognition or other neuropsychological measures. However, subgroup analysis revealed a significant three-way interaction between apolipoprotein E ( APOE ) allele 4 status, tDCS condition, and time. APOE4 -positive patients receiving HD-tDCS showed significantly greater improvement in language function, as measured by the Wechsler Adult Intelligence Scale Fourth Edition vocabulary, compared to APOE4 -negative patients in the sham group (p = 0.028). Adverse effects were mild and comparable between groups.

Conclusions

HD-tDCS did not enhance global cognition in MCI patients overall. Preliminary findings demonstrated a potential language benefit was observed in APOE4 -postitive individuals. These exploratory findings warrant further investigation in larger, biomarker-stratified studies.

Trial registration

The study was registered at ClinicalTrial.gov under NCT04121156.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionTranscranial Direct Current StimulationAgedFemaleHumansMaleMiddle AgedCognitionDouble-Blind MethodNeuropsychological TestsTreatment OutcomePilot Projects

Stichwörter der Autor:innen

Alzheimer's diseaseapolipoprotein Ehigh-definition transcranial direct current simulationlanguagemild cognitive impairmentrandomized

Autor:innen und Institutionen

  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  • Center for Geriatrics and Gerontology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  • Non-invasive Neuromodulation Consortium for Mental Disorders, Society of Psychophysiology, Taipei, Taiwan.
  • Department of Psychiatry, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
  • Division of Neurology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

ORCID-Profile: Che-Sheng Chu, Chih-Kuang Liang, Ying-Hsin Hsu

Förderung

  • the National Science and Technology
  • Kaohsiung Veterans General Hospital
  • National Health Research Institutes

Zitieren

APA

Chu, C. S., Chang, H. A., Lin, Y. T., Shen, H. C., Liang, C. K., Hsu, Y. H., Pan, C. C., Kuo, H. Y., Liang, W. Z., Chen, S. L., & Chen, C. S. (2025). Effectiveness and safety of high-definition transcranial direct current stimulation in patients with mild cognitive impairment: A randomized, triple-blind, sham-controlled trial. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251376547

Vancouver

Chu CS, Chang HA, Lin YT, Shen HC, Liang CK, Hsu YH, et al. Effectiveness and safety of high-definition transcranial direct current stimulation in patients with mild cognitive impairment: A randomized, triple-blind, sham-controlled trial. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251376547

BibTeX
@article{Chu2025,
  author = {Chu, Che-Sheng and Chang, Hsin-An and Lin, Yu-Te and Shen, Hsiu-Chu and Liang, Chih-Kuang and Hsu, Ying-Hsin and Pan, Chih-Chuan and Kuo, Hsin-Ya and Liang, Wei-Zhe and Chen, Shiou-Lan and Chen, Cheng-Sheng},
  title = {Effectiveness and safety of high-definition transcranial direct current stimulation in patients with mild cognitive impairment: A randomized, triple-blind, sham-controlled trial},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251376547}
}
Kostenlos starten →